Inotuzumab Ozogamicin vs Tofacitinib
Inotuzumab Ozogamicin vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Inotuzumab Ozogamicin and Tofacitinib.
Mechanism of Action
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Tofacitinib β 3.2 hours.
Chemical Properties
Molecular Formula: Tofacitinib β C16H20N6O.
Molecular Weight: Tofacitinib β 312.3700 g/mol.
Type: Inotuzumab Ozogamicin β Antibody drug conjugate; Tofacitinib β Small molecule.